Inventiva S.A. Announces Share Subscription Agreements

TL;DR

Inventiva S.A. is selling shares/warrants to investors on Oct 11, 2024, to raise cash.

AI Summary

On October 11, 2024, Inventiva S.A. entered into subscription agreements with certain investors to issue and sell ordinary shares or pre-funded warrants. This action is part of a financing round, details of which are not fully disclosed in this excerpt.

Why It Matters

This filing indicates Inventiva S.A. is raising capital through the issuance of new shares or warrants, which could impact its financial structure and future operations.

Risk Assessment

Risk Level: medium — The company is issuing new equity, which can dilute existing shareholders and suggests a need for capital, potentially indicating financial pressures.

Key Players & Entities

• Inventiva S.A. (company) — Registrant and issuer of shares/warrants
• October 11, 2024 (date) — Date of subscription agreements
• T1 Subscription Agreement (document) — Name of the agreement
• Investors (group) — Parties purchasing shares/warrants
• ordinary shares (security) — Type of shares being issued
• pre-funded warrants (security) — Alternative to shares being issued

FAQ

Key Financial Figures

• $30 million — TTQ has agreed to pay the Company up to $30 million upon the achievement of certain fundrai
• $10 million — and clinical milestones, including (i) $10 million upon completion of the first tranche of
• $90 m — he first tranche of the Equity Raise of $90 million, (ii) $10 million upon completion
• $10 million — f the Equity Raise of $90 million, (ii) $10 million upon completion of the second tranche o
• $90 million — e second tranche of the Equity Raise of $90 million and (iii) $10 million upon the publicat

Filing Documents

• tm2426119d2_6k.htm (6-K) — 32KB
• tm2426119d2_ex99-1.htm (EX-99.1) — 592KB
• tm2426119d2_ex99-3.htm (EX-99.3) — 24KB
• tm2426119d2_ex99-4.htm (EX-99.4) — 239KB
• tm2426119d2_ex99-2img01.jpg (GRAPHIC) — 3KB
• tm2426119d2_ex99-2img02.jpg (GRAPHIC) — 2KB
• tm2426119d2_ex99-2img03.jpg (GRAPHIC) — 1KB
• 0001104659-24-108263.txt ( ) — 897KB

Forward-Looking Statements

Forward-Looking Statements This Report of Foreign Private Issuer on Form 6-K contains “forward-looking other than statements of historical facts, included in this Form 6-K are forward-looking statements. These statements include, but are not limited to, the timing and completion of the Transaction; the anticipated proceeds from the Transaction and the Company’s expected use of such proceeds; the satisfaction, in part or full of the conditions precedent to the issuance of the T1bis Securities and the ABSAs; the occurrence of the triggering event for the exercise of the T3 BSAs; the exercise of the Investors of the ordinary shares underlying the pre-funded warrants or T3 BSAs in full or in part; the Company’s expectations regarding its collaboration agreement with CTTQ, including the achievement of specified milestones thereunder; and the Company’s expectations with respect to its clinical trials, including NATiV3. Certain of these statements, forecasts and estimates can be recognized by the use of words such as, without limitation, “believes”, “anticipates”, “expects”, “intends”, “plans”, “seeks”, “estimates”, “may”, “will”, “would”, “could”, “might”, “should”, and “continue” and similar expressions. Such statements are not historical facts but rather are statements of future expectations and other forward-looking statements that are based on management’s beliefs. These statements reflect such views and assumptions prevailing as of the date of the statements and involve known and unknown risks and uncertainties that could cause future results, performance or future events to differ materially from those expressed or implied in such s

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inventiva S.A. Date: October 15, 2024 By: /s/ Frédéric Cren Name Frédéric Cren Title: Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR